Elixirr International Plc (GB:ELIX)
LSE:ELIX
Want to see GB:ELIX full AI Analyst Report?
Top Page
Elixirr International Plc
(LSE:ELIX)
Select Model
Select Model
Rating:76Outperform
Price Target:
836.00 p
▼(-0.48% Downside)
Action:ReiteratedDate:04/22/26
The score is driven primarily by strong financial fundamentals (scaled revenue, healthy margins, solid returns), tempered by increased 2025 leverage and weaker operating cash support. Technicals are supportive with positive momentum but show near-term overbought risk and lingering overhead versus the 200-day average. Valuation is reasonable but not notably cheap, and the dividend yield is modest.
Positive Factors
Revenue scaling
Multi-year revenue scaling demonstrates durable client demand and the firm’s ability to win larger or more frequent engagements. Sustained top-line growth supports reinvestment in talent and capabilities, reducing reliance on single large projects and improving long-term business resilience.
Negative Factors
Sharp rise in debt
A large increase in absolute debt after a historically low-leverage profile reduces financial flexibility and raises refinancing and covenant risk. Higher leverage limits ability to absorb shocks or fund opportunistic investments without increasing financing costs over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue scaling
Multi-year revenue scaling demonstrates durable client demand and the firm’s ability to win larger or more frequent engagements. Sustained top-line growth supports reinvestment in talent and capabilities, reducing reliance on single large projects and improving long-term business resilience.
Read all positive factors
Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£375.30M
Dividend Yield2.13%
Average Volume (3M)101.98K
Price to Earnings (P/E)20.0
Beta (1Y)1.01
Revenue Growth34.36%
EPS Growth17.53%
CountryUK
Employees565
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)0.18
Shares Outstanding50,031,155
10 Day Avg. Volume75,512
30 Day Avg. Volume101,977
Financial Highlights & Ratios
PEG Ratio1.17
Price to Book (P/B)2.76
Price to Sales (P/S)2.63
P/FCF Ratio12.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£1,060.00Price Target Upside26.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.65
Revenue Forecast (FY)£185.75M
Elixirr International Plc Business Overview & Revenue Model
Company Description
Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers...
How the Company Makes Money
Elixirr primarily makes money by selling consulting and professional services to client organisations. Revenue is generated through fees for advisory work (e.g., strategy, transformation design, operating model and performance improvement) and del...
Elixirr International Plc Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
76
Positive
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 149.60M | 111.34M | 85.89M | 71.75M | 50.61M |
| Gross Profit | 44.80M | 35.81M | 29.26M | 23.16M | 17.70M |
| EBITDA | 39.55M | 27.96M | 25.78M | 20.02M | 14.46M |
| Net Income | 19.70M | 16.38M | 17.24M | 12.87M | 10.14M |
Balance Sheet | |||||
| Total Assets | 251.08M | 175.89M | 154.40M | 128.66M | 107.17M |
| Cash, Cash Equivalents and Short-Term Investments | 5.05M | 7.53M | 18.13M | 20.43M | 31.80M |
| Total Debt | 33.52M | 4.90M | 5.36M | 5.14M | 5.25M |
| Total Liabilities | 108.56M | 43.78M | 34.84M | 32.74M | 21.13M |
| Stockholders Equity | 142.53M | 132.11M | 119.56M | 95.92M | 86.04M |
Cash Flow | |||||
| Free Cash Flow | 31.48M | 28.76M | 16.67M | 15.40M | 14.23M |
| Operating Cash Flow | 31.55M | 28.84M | 16.79M | 15.73M | 14.33M |
| Investing Cash Flow | -36.56M | -21.11M | -14.82M | -18.53M | -3.24M |
| Financing Cash Flow | 2.92M | -18.58M | -4.06M | -8.85M | 3.11M |
Elixirr International Plc Technical Analysis
Neutral
840.00
Price Trends
671.76
Positive
737.01
Negative
755.41
Negative
Market Momentum
12.89
Negative
62.24
Neutral
86.10
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Neutral. The current price of 840 is above the 20-day moving average (MA) of 644.50, above the 50-day MA of 671.76, and above the 200-day MA of 755.41, indicating a neutral trend. The MACD of 12.89 indicates Negative momentum. The RSI at 62.24 is Neutral, neither overbought nor oversold. The STOCH value of 86.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:ELIX.
Elixirr International Plc Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.79B | 19.41 | 16.69% | 1.27% | 1.69% | 276.44% | |
77 Outperform | £221.14M | 10.47 | 6.46% | 3.68% | 2.11% | 818.58% | |
76 Outperform | £375.30M | 19.98 | 14.71% | 2.13% | 34.36% | 17.53% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £773.78M | 24.99 | 9.94% | 1.19% | 12.82% | 16.40% | |
60 Neutral | £95.40M | 7.60 | 6.42% | 8.80% | 6.04% | -24.55% | |
41 Neutral | £335.38M | -2.81 | -142.88% | ― | -7.30% | -311.68% |
* Industrials Sector Average
GB:ELIX
Elixirr International Plc
768.00
76.40
11.05%
GB:CPI
Capita plc
280.00
88.90
46.52%
GB:GTLY
Gateley (Holdings)
70.00
-49.14
-41.25%
GB:DATA
GlobalData
105.00
-29.27
-21.80%
GB:SRP
Serco Group plc
282.00
116.21
70.10%
GB:YOU
Yougov plc
186.30
-84.96
-31.32%
Elixirr International Plc Corporate Events
Business Operations and StrategyDelistings and Listing ChangesDividendsFinancial DisclosuresM&A Transactions
Elixirr posts record 2025 results as AI-led consulting drives 34% revenue surge
Positive
Apr 20, 2026
Elixirr International reported record results for 2025, with revenue rising 34% to £149.6m and adjusted EBITDA up 42% to £44.3m, driven by strong demand for AI-enabled advisory work and disciplined execution. The group lifted its total d...
Business Operations and StrategyFinancial Disclosures
Elixirr Schedules Live Investor Presentation on FY25 Results
Positive
Mar 27, 2026
Elixirr International will host a live investor presentation on 21 April 2026 to discuss its full‑year 2025 results, which are scheduled for release on 20 April 2026. The session, led by senior executives including the CEO, Deputy CEO, CFO a...
Business Operations and StrategyExecutive/Board Changes
Elixirr grants new share options to senior leadership
Positive
Mar 23, 2026
Elixirr International has granted 444,912 share options over ordinary shares to its executive directors and other senior managers, representing about 0.89% of its issued share capital. The options, priced at 645 pence with a five-year vesting peri...
Regulatory Filings and Compliance
Elixirr Non-Executive Director Increases Stake with Share Purchase
Positive
Mar 19, 2026
Elixirr International plc disclosed that non-executive director Simon Retter purchased 1,619 ordinary shares in the company on 18 March 2026 at 636.00 pence per share. The transaction increases his beneficial holding to 246,443 shares, representin...
Regulatory Filings and Compliance
Elixirr Non-Executive Director Increases Stake Through Market Purchase
Positive
Feb 27, 2026
Elixirr International reported that non-executive director Simon Retter bought 883 ordinary shares and his daughter, Evelyn Retter, acquired 382 shares in the company at 679.50 pence each. Following these purchases, Retter’s total beneficial...
Regulatory Filings and Compliance
Elixirr Non-Executive Director Increases Stake in Challenger Consultancy
Positive
Feb 25, 2026
Elixirr International plc reported that non-executive director Simon Retter bought 1,476 ordinary shares at 677.20 pence each on 24 February 2026. Following the transaction, Retter holds 243,559 shares, representing about 0.49% of the company̵...
Business Operations and StrategyM&A Transactions
Elixirr Enters Nordics with Earnings-Enhancing Acquisition of Kvadrant Consulting
Positive
Feb 2, 2026
Elixirr International plc has acquired Denmark-based Kvadrant Consulting A/S, a fast-growing consultancy specialising in commercial transformation, go-to-market excellence and transaction services, for up to DKK154.8 million (£18.0 million) i...
Business Operations and StrategyExecutive/Board Changes
Elixirr strengthens board with appointment of former KPMG UK chair Bill Michael
Positive
Jan 30, 2026
Elixirr International plc has appointed former KPMG UK chairman and senior partner Bill Michael as a non-executive director with immediate effect, bringing nearly three decades of professional services and board-level governance experience to its ...
Business Operations and StrategyDividendsFinancial Disclosures
Elixirr Lifts Interim Dividend as Strong 2025 Trading Bolsters FTSE 250 Ambition
Positive
Jan 22, 2026
Elixirr International reported that, subject to audit, full-year 2025 revenue and adjusted EBITDA margins are expected to meet or exceed market forecasts, underpinned by record cross‑selling, an expanding roster of high‑value “go...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.